Trial
NCT05161533
Hypofractionated Radiation Therapy After Durvalumab and Chemotherapy for the Treatment of Stage IV Extensive Stage Small Cell Lung Cancer, CASPIAN-RT Trial
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Washington
Collaborators
AstraZeneca
Condition
Extensive Stage Lung Small Cell Carcinoma
Intervention
Carboplatin
Why stopped
Closed per SRC Low Accrual Policy. Study closed prior to any participants enrolled.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-10-18